| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 475.73M | 453.51M | 339.94M | 267.27M | 253.30M |
| Gross Profit | 64.23M | 99.83M | 91.23M | 94.67M | 103.43M |
| EBITDA | 101.28M | 98.33M | 73.23M | 39.60M | 42.23M |
| Net Income | 32.48M | 37.01M | 39.20M | 33.60M | 33.44M |
Balance Sheet | |||||
| Total Assets | 932.84M | 834.83M | 845.28M | 450.12M | 372.89M |
| Cash, Cash Equivalents and Short-Term Investments | 178.66M | 173.29M | 212.65M | 250.05M | 254.32M |
| Total Debt | 342.57M | 296.39M | 289.88M | 0.00 | 122.00K |
| Total Liabilities | 607.07M | 560.73M | 532.68M | 151.48M | 123.64M |
| Stockholders Equity | 313.34M | 268.71M | 305.41M | 296.95M | 249.01M |
Cash Flow | |||||
| Free Cash Flow | 94.44M | 55.80M | -8.26M | -32.35M | 15.88M |
| Operating Cash Flow | 107.29M | 72.13M | 43.43M | -22.31M | 17.17M |
| Investing Cash Flow | -129.78M | -24.77M | -71.58M | -12.69M | -8.19M |
| Financing Cash Flow | 31.99M | -88.37M | -12.90M | 19.48M | 132.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$840.38M | ― | 6.41% | 8.44% | 14.21% | -7.54% | |
71 Outperform | HK$1.92B | 3.90 | 33.20% | ― | 1.00% | 31.99% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
54 Neutral | HK$785.91M | -0.24 | -8.08% | 4.04% | 11.90% | -374.23% | |
52 Neutral | HK$2.91B | 30.35 | 10.94% | ― | 7.77% | -7.65% | |
50 Neutral | HK$892.50M | -3.16 | -3.07% | 6.22% | -3.09% | 62.33% | |
42 Neutral | HK$214.78M | -1.05 | 4.36% | ― | -5.08% | -682.55% |